NLRP3炎症酶激活与基尼胺诱导的肝毒性有关
Yixuan Liu1, Baoyue Liu1, Mingzhu Shi1
1School of Chinese Medicine and Food Engineering, Shanxi University of Traditional Chinese Medicine, Jinzhong 030619, China.
Mediators of inflammation
|February 14, 2025
概括
热尼胺通过激活NOD类受体蛋白3 (NLRP3) 炎症体而引起肝脏毒性. 抑制NLRP3炎症酶信号提供了一个潜在的治疗策略,以减轻基尼胺诱导的肝损伤.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基尼化物是一种来自Gardenia jasminoides的化合物,具有药理上的好处,但与肝脏毒性有关.
- 类似NOD的受体蛋白3 (NLRP3) 炎酶体参与各种病理,包括药物诱导的肝损伤.
研究的目的:
- 为了研究NLRP3炎症酶在基因胺诱导的肝毒性中的作用.
- 评估抑制NLRP3炎症酶信号传导对抗基因胺诱导的肝损伤的治疗潜力.
主要方法:
- 在老鼠和HL-7702细胞中,用或不用glibenclamide (NLRP3抑制剂) 给药基尼化物.
- 评估肝损伤标志物 (酶,胆红素),炎症性细胞因子 (IL-1β,IL-18) 和炎症组分 (NLRP3,ASC,caspase-1) 通过生物化学测试,ELISA,RT-PCR和西布测试.
主要成果:
- 基尼胺治疗导致严重的肝损伤,肝酶升高,IL-1β和IL-18水平增加,与NLRP3炎症酶激活相关.
- 在细胞中暴露于基尼会降低活力,增加炎症标志物和NLRP3炎症酶表达.
- Glibenclamide 治疗减弱了 NLRP3 激活,减少了炎症,并防止了基尼胺诱导的肝损伤.
结论:
- 热尼胺通过激活NLRP3炎症体信号通路来诱导肝毒性.
- 向NLRP3炎症酶组代表了一种有前途的治疗方法,用于管理基尼胺诱导的肝毒性.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...


